Filter Results:
(128)
Show Results For
- All HBS Web
(378)
- People (2)
- News (141)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
Show Results For
- All HBS Web
(378)
- People (2)
- News (141)
- Research (128)
- Events (2)
- Multimedia (6)
- Faculty Publications (71)
Sort by
- 02 Apr 2001
- Research & Ideas
Not All M&As Are Alike—and That Matters
Scenario 4: The M&a As R&d The next-to-last category, acquisitions as a substitute for in-house R&D, is related to product and market extensions, but I'll treat it separately because it's so new and untested. An assortment of high-tech and View Details
Keywords: by Joseph L. Bower
- 11 Apr 2011
- Lessons from the Classroom
Teaching a ‘Lean Startup’ Strategy
in the clean tech and biotech fields, both of which often require a great deal of time and capital to create any workable product. The same is true of the transportation industry—inventor Dean Kamen's Segway, for example, or startup... View Details
- 30 Jun 2021
- In Practice
The Harvard Business School Faculty Summer Reader 2021
many products and offer countless tips on how to lower your carbon footprint every day. Julia Austin (@austinfish) is an executive fellow at the Rock Center for Entrepreneurship and a former senior lecturer. Jeffrey Bussgang: Civil rights and View Details
Keywords: by Kathryn Haviland
- 15 Jun 2007
- Research & Ideas
Remembering Alfred Chandler
School, Al was just publishing Scale and Scope. I watched him move from this book, which dealt principally with Second Industrial Revolution industries, to a keen interest in telecommunications and the Information Revolution. Before long, Al was digging into View Details
Keywords: by Sean Silverthorne
- 15 Feb 2000
- Research & Ideas
The Right Connections
capital on their ability to secure resources. "In biotech it can take eight to ten years to develop a product and cost hundreds of millions of dollars to bring it to market," says Higgins. "Therefore, funding is... View Details
Keywords: by Judith A. Ross
- 07 Feb 2005
- Research & Ideas
How “Career Imprinting” Shapes Leaders
top biotech managers, companies leave an imprint of their worldview on young executives through such things as the firm's structure, strategy, and culture. There is a GE imprint, an IBM imprint, a Bain imprint—all of which influence... View Details
Keywords: by Mallory Stark
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
research projects. A: There is a whole bunch of work being done on biotech, the biotech industry, and the future of pharmaceuticals. My stuff looks at a broader question: Can science be a business? This is the history of biotech, which is... View Details
- 18 Oct 2010
- Lessons from the Classroom
Venture Capital’s Disconnect with Clean Tech
MBA students often fall into one of two categories—those hungry to rush into careers as venture capitalists, and those eager to found a venture-funded start-up. For all of them, Harvard Business School professor Joseph Lassiter has some intriguing advice: Spend a few... View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
Jeffrey Wiesen, an attorney specializing in biotechnology, the standard routine was "more a work-for-hire model than a collaboration model, although we always called it collaboration." In a nutshell, it worked like this, Wiesen said. "A View Details
- 09 Aug 2010
- Research & Ideas
How to Speed Up Energy Innovation
Is there a special sauce for stimulating innovation in the energy sector, a concoction to spur cost-effective developments toward solving the climate change problem? HBS professor Rebecca Henderson doesn't claim to know all the ingredients for that special sauce. But... View Details
- 12 Oct 2006
- First Look
First Look: October 12, 2006
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707438 PublicationsScience Business: Promise, Performance and the Future of Biotech Author:Gary P. Pisano Publication:Harvard Business School Press (forthcoming) Abstract... View Details
Keywords: Sean Silverthorne
- 26 Nov 2001
- Research & Ideas
Women Entrepreneurs Use Springboard for Funding
personalize healthcare and benefits, and Carol Nacy of Sequella, Inc., a biotech firm focused on controlling global infectious diseases, especially tuberculosis. Most of the companies were already up and running. Their funding to date has... View Details
Keywords: by Martha Lagace
- 19 Sep 2012
- Research & Ideas
Funding Innovation: Is Your Firm Doing it Wrong?
its traditional slow-paced and bureaucratic system of R&D to emulate the relatively fast pace and entrepreneurial system of biotech companies." The firm created several specialized research teams to manage the innovation process.... View Details
Keywords: by Carmen Nobel
- 01 Mar 2018
- What Do You Think?
Two Decades Later, is the 'New Economy' Finally Here?
second of these books, Exponential Organizations (“ExOs”), explores the impact of new technologies on organizations. These are organizations driven by such things as AI, robotics, biotech and bioinformatics, data science, and 3D printing.... View Details
Keywords: by James Heskett
- 20 Jul 2015
- Research & Ideas
Globalization Hasn’t Killed the Manufacturing Cluster
the federal government to create new clusters in the United States. He points to the rise of biotech in Harvard's backyard, which began despite government opposition in the 1970s. Clusters "tend to emerge much more organically, and they... View Details
- 06 May 2008
- First Look
First Look: May 6, 2008
Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Business School Case 808-005 In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora... View Details
Keywords: Martha Lagace
- 06 Feb 2007
- First Look
First Look: February 6, 2007
Harvard Business School Supplement 107-049 Supplements the (A) case. Purchase this supplement: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=107049 Monsanto: Realizing Biotech Value in Brazil Harvard Business School Case... View Details
Keywords: Martha Lagace
- 17 Oct 2006
- First Look
First Look: October 17, 2006
founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even... View Details
Keywords: Sean Silverthorne
- 04 Apr 2022
- Research & Ideas
Tech Hubs: How Software Brought Talent and Prosperity to New Cities
move to one of the big tech clusters like San Francisco,” Kerr says. “Likewise, if you are a biotech entrepreneur, there are enormous advantages to being in the Boston area. But there are also a lot of inventors who work in spaces that... View Details
Keywords: by Rachel Layne
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
case:https://hbsp.harvard.edu/product/318082-PDF-ENG Harvard Business School Case 318-083 Sandra Brown Goes Digital (B): The Commitment Decision Sandra Brown, a middle manager at a biotech company who has led internal and external... View Details
Keywords: Dina Gerdeman